Esophageal Acidification During Nocturnal Acid-breakthrough with Ilaprazole Versus Omeprazole in Gastroesophageal Reflux Disease

BACKGROUND/AIMS: Though nocturnal acid-breakthrough (NAB) is common in gastroesophageal reflux disease (GERD) patients, its clinical importance results from esophageal acidification, which has been shown to be uncommon. Ilaprazole, a long-acting proton pump inhibitor, may cause NAB infrequently. Acc...

Descripción completa

Detalles Bibliográficos
Autores principales: Karyampudi, Arun, Ghoshal, Uday C, Singh, Rajan, Verma, Abhai, Misra, Asha, Saraswat, Vivek A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Neurogastroenterology and Motility 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383115/
https://www.ncbi.nlm.nih.gov/pubmed/27585842
http://dx.doi.org/10.5056/jnm16087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383115/
https://www.ncbi.nlm.nih.gov/pubmed/27585842
http://dx.doi.org/10.5056/jnm16087

Ejemplares similares